Skip to content

A Retrospective Study of the Usefulness of Hydrocortisone Prophylaxis for Oxaliplatin-induced Hypersensitivity Reactions

A Retrospective Study of the Usefulness of Hydrocortisone Prophylaxis for Oxaliplatin-induced Hypersensitivity Reactions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030240152
Enrollment
Unknown
Registered
2024-06-11
Start date
2024-06-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal cancer

Interventions

None listed

Sponsors

Nishimura Takahiro
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who received oxaliplatin as treatment for gastrointestinal cancer at our hospital between January 2017 and December 2023.

Exclusion criteria

Exclusion criteria: Patients who have expressed their refusal to participate in this study

Design outcomes

Primary

MeasureTime frame
Allergy incidence

Contacts

Public ContactMaho Tanaka

Japan Institute for Health Security

tanaka.ma@jihs.go.jp+81-332027181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026